AmeriCann, Inc.
ACAN
$0.0638
$0.023859.50%
| Weiss Ratings | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.49 | |||
| Price History | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 79.21% | |||
| 30-Day Total Return | 112.67% | |||
| 60-Day Total Return | 258.43% | |||
| 90-Day Total Return | 112.67% | |||
| Year to Date Total Return | 91.59% | |||
| 1-Year Total Return | -1.85% | |||
| 2-Year Total Return | -74.41% | |||
| 3-Year Total Return | -85.66% | |||
| 5-Year Total Return | -89.79% | |||
| 52-Week High % Change | -28.87% | |||
| 52-Week Low % Change | 314.29% | |||
| Price | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.09 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Nov 18, 2024 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.56M | |||
| Enterprise Value | 8.21M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.10 | |||
| Earnings Per Share Growth | 597.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.95 | |||
| Price/Book (Q) | 0.49 | |||
| Enterprise Value/Revenue (TTM) | 10.28 | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | -11.60 | |||
| Enterprise Value/EBIT | -7.13 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.39M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (303) 862-9000 | |||
| Address | 1555 Blake Street Denver, CO 80202 | |||
| Website | americann.co | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -144.20% | |||
| Profit Margin | -297.88% | |||
| Management Effectiveness | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.74% | |||
| Return on Equity | -- | |||
| Income Statement | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 799.30K | |||
| Total Revenue (TTM) | 799.30K | |||
| Revenue Per Share | $0.03 | |||
| Gross Profit (TTM) | 797.70K | |||
| EBITDA (TTM) | -707.90K | |||
| EBIT (TTM) | -1.15M | |||
| Net Income (TTM) | -2.38M | |||
| Net Income Avl. to Common (TTM) | -2.38M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -655.06% | |||
| EPS Diluted (TTM) | -0.10 | |||
| EPS Diluted Growth (Q YOY) | -432.00% | |||
| Balance Sheet | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 131.20K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 478.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.15M | |||
| Current Ratio (Q) | 0.090 | |||
| Book Value Per Share (Q) | $0.13 | |||
| Total Assets (Q) | 10.14M | |||
| Total Current Liabilities (Q) | 5.28M | |||
| Total Debt (Q) | 6.79M | |||
| Total Liabilities (Q) | 6.99M | |||
| Total Common Equity (Q) | 3.15M | |||
| Cash Flow | ACAN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 749.90K | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -676.50K | |||
| Levered Free Cash Flow (TTM) | -371.90K | |||
| Cash from Operations (TTM) | -1.43M | |||
